Is Scandinavia ready for Aquablation? Reflections on the WATER III Trial
DOI:
https://doi.org/10.2340/sju.v61.46999Downloads
References
Ritter M, Stein J, Barber N, et al. WATER III: A prospective, partially randomized trial of aquablation therapy versus transurethral laser enucleation of the prostate for treatment of lower urinary tract symptoms. Eur Urol Focus. 2026;12(2):266–274. DOI: https://doi.org/10.1016/j.euf.2026.01.006
Bjarnason J, Ingimarsson JP, Thorisson H, et al. Prostate artery embolization for benign prostatic hyperplasia: A retrospective single-center study of clinical outcome. Scand J Urol. 2025;60:130–134. DOI: https://doi.org/10.2340/sju.v60.44137
Carl Fredrik Knobloch, May Lisbeth Plathan, Sven Löffeler, et al. AS-5.075 Perioperativ Results Following Implementation of TUEP in Vestfold. Abstract book for the 35th Congress of the Scandinavian Association of Urology (NUF). Scand J Urol. 2025;60(Supp 223):1–40. DOI: https://doi.org/10.2340/sju.v60.44124
Petrosyan V, Cronhjort M, Albert J, et al. All cause 90-day mortality associated with TUR-P procedure: A Swedish quality register-based study (2013–2022). Scand J Urol. 2026;61:216–222. DOI: https://doi.org/10.2340/sju.v61.46751
Blissett D, Sagen E, Kvan E, et al. Expanding treatments for lower urinary tract symptoms, secondary to benign prostatic enlargement: A capacity and budget impact analysis in four Nordic countries. Scand J Urol. 2025;60:164–172. DOI: https://doi.org/10.2340/sju.v60.44243
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Patrick Juliebø-Jones, Jill-Randi Harneshaug, Stephen Baug
This work is licensed under a Creative Commons Attribution 4.0 International License.
As from Volume 59 (2024) all published articles, unless otherwise specified, are published under CC-BY license, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, with the condition of proper attribution to the original work.
